Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Pleural Effusion, Malignant 5Neoplasm Metastasis 4Solitary Fibrous Tumor, Pleural 1Mesothelioma, Malignant 1Mesothelioma 1Lung Diseases 1

Interventions

Pemetrexed 5Nivolumab 4Cisplatin 4Carboplatin 4Ipilimumab 3durvalumab 1atezolizumab 1Vorinostat 1Talc 1Surveys and Questionnaires 1Radiotherapy, Intensity-Modulated 1Radiation 1Platinum 1Injections 1Cerebral Decortication 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Mesothelioma × Talc × Clear all
NCT02511600 2015-12-15

Comparison of Progel Sealant to Standard of Care (SOC) for Patients Undergoing Decortication

M.D. Anderson Cancer Center

Phase 3 Withdrawn
Other solid neoplasmThoracic

Lung Diseases, Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡